magnesium sulfate has been researched along with Infarction, Middle Cerebral Artery in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demin, TV; Islaamov, RR; Khafiz'ianova, RKh; Khasanova, DR; Kitaeva, EA; Saĭkhunov, MV | 1 |
| Gomibuchi, H; Hara, T; Kakogawa, J; Kimura, A; Masuya, N; Minoura, S; Oda, H; Ohno, H; Sadatsuki, M | 1 |
| Ji, YB; Ji, Z; Pan, SY; Song, W; Wang, SN; Wu, YM | 1 |
| Bloos, G; Harscher, S; Möller, U; Pfleiderer, SO; Terborg, C; Witte, OW | 1 |
| Boet, R; Chan, MT; Gin, T; Ng, SC; Poon, WS | 1 |
| Cheng, FC; Chung, SY; Lee, MS; Lin, JY; Lin, MC; Wang, MF | 1 |
2 trial(s) available for magnesium sulfate and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
[Amantadine sulfate (PK-Merz) in the treatment of ischemic stroke: a clinical-experimental study].
Topics: Aged; Aged, 80 and over; Amantadine; Animals; Blotting, Western; Calcium Channel Blockers; Consciousness; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; HSP70 Heat-Shock Proteins; Humans; Immunohistochemistry; Infarction, Middle Cerebral Artery; Magnesium Sulfate; Male; Middle Aged; Rats; Rats, Wistar; Recovery of Function; Treatment Outcome | 2009 |
Magnesium sulfate for brain protection during temporary cerebral artery occlusion.
Topics: Brain; Brain Ischemia; Female; Humans; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Oxygen; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents | 2005 |
4 other study(ies) available for magnesium sulfate and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Antepartum intracranial hemorrhage due to unrecognized unilateral moyamoya disease: a case report.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Antihypertensive Agents; Aspartate Aminotransferases; Cesarean Section; Emergencies; Female; Headache; HELLP Syndrome; Hemiplegia; Humans; Infant, Newborn; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; L-Lactate Dehydrogenase; Magnesium Sulfate; Male; Moyamoya Disease; Platelet Transfusion; Pregnancy; Puerperal Disorders; Tomography, X-Ray Computed; Unconsciousness | 2011 |
Intra-carotid cold magnesium sulfate infusion induces selective cerebral hypothermia and neuroprotection in rats with transient middle cerebral artery occlusion.
Topics: Analysis of Variance; Animals; Brain Edema; Brain Infarction; Cerebral Cortex; Disease Models, Animal; Hypothermia, Induced; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Magnesium Sulfate; Male; Nervous System Diseases; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Time Factors | 2013 |
[Cerebral vasospasms with hemodynamic infarctions as a complication of HELLP syndrome].
Topics: Adult; Cesarean Section; Diagnostic Imaging; Dose-Response Relationship, Drug; Female; Follow-Up Studies; HELLP Syndrome; Humans; Infarction, Middle Cerebral Artery; Magnesium Sulfate; Methylprednisolone; Neurologic Examination; Neuropsychological Tests; Nimodipine; Postoperative Complications; Pregnancy; Pregnancy Trimester, Third; Puerperal Disorders; Vasospasm, Intracranial | 2003 |
Ginkgo biloba leaf extract (EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain.
Topics: Animals; Brain Infarction; Brain Ischemia; Dizocilpine Maleate; Drug Therapy, Combination; Gerbillinae; Ginkgo biloba; Infarction, Middle Cerebral Artery; Magnesium Sulfate; Male; Neuroprotective Agents; Plant Extracts; Random Allocation; Tacrolimus; Treatment Outcome | 2006 |